fluorodeoxyglucose f18 has been researched along with Alveolar Soft Part Sarcoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, N; Wang, S; Yang, Z; Zhou, X; Zhu, H | 1 |
| Asano, Y; Hirakawa, K; Kashiwagi, S; Ohira, M; Ohsawa, M; Takada, K; Takashima, T; Tokimasa, S | 1 |
| Cheng, C; Dong, A; Wang, Y; Zuo, C | 1 |
| Absher, K; Conrad, GR; Montgomery, JR; Sinha, P | 1 |
4 other study(ies) available for fluorodeoxyglucose f18 and Alveolar Soft Part Sarcoma
| Article | Year |
|---|---|
Imaging superiority of [
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines; Sarcoma, Alveolar Soft Part | 2021 |
Alveolar soft part sarcoma metastatic to the breast: a case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cheek; Child; Facial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mastectomy, Segmental; Positron-Emission Tomography; Sarcoma, Alveolar Soft Part; Skull Neoplasms; Tomography, X-Ray Computed; Ultrasonography | 2019 |
CT, MRI, and FDG PET/CT in a patient with alveolar soft part sarcoma.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoma, Alveolar Soft Part; Tomography, X-Ray Computed | 2014 |
FDG PET of alveolar soft part sarcoma.
Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoma, Alveolar Soft Part; Tomography, X-Ray Computed | 2010 |